These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 10197802

  • 1. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ.
    Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
    [Abstract] [Full Text] [Related]

  • 2. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
    Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Tydén G.
    Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
    [Abstract] [Full Text] [Related]

  • 3. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T, Lai WK, Gow P, Leeming J, Mutimer D.
    Transpl Infect Dis; 2005 Dec; 7(3-4):126-32. PubMed ID: 16390401
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 5. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC.
    Mycoses; 1999 Dec; 42 Suppl 2():121-4. PubMed ID: 10865918
    [Abstract] [Full Text] [Related]

  • 6. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
    Ringdén O, Andström EE, Remberger M, Dahllöf G, Svahn BM, Tollemar J.
    Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
    [Abstract] [Full Text] [Related]

  • 7. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.
    N Engl J Med; 1999 Mar 11; 340(10):764-71. PubMed ID: 10072411
    [Abstract] [Full Text] [Related]

  • 8. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 9. [Prophylaxis against mycoses in neutropenic patients].
    Arning M, Aul C.
    Mycoses; 1994 Jan 15; 37 Suppl 2():70-6. PubMed ID: 7541892
    [Abstract] [Full Text] [Related]

  • 10. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 15; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 11. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS, Parikh PM, Kulkarni PS, Bhagwat R, Gadade H.
    J Postgrad Med; 2005 Nov 15; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [Abstract] [Full Text] [Related]

  • 12. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N.
    Clin Infect Dis; 1999 Feb 15; 28(2):331-40. PubMed ID: 10064252
    [Abstract] [Full Text] [Related]

  • 13. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Löwenberg B, Vulto A, Lugtenburg PJ, de Marie S.
    Clin Infect Dis; 2008 May 01; 46(9):1401-8. PubMed ID: 18419443
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A.
    Cancer; 2000 Oct 01; 89(7):1611-25. PubMed ID: 11013378
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
    Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W.
    Clin Infect Dis; 2000 Feb 01; 30(2):300-5. PubMed ID: 10671332
    [Abstract] [Full Text] [Related]

  • 16. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.
    Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagańo L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F.
    Clin Infect Dis; 1999 Feb 01; 28(2):250-5. PubMed ID: 10064240
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W.
    Transplantation; 2003 Sep 27; 76(6):977-83. PubMed ID: 14508365
    [Abstract] [Full Text] [Related]

  • 18. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 19. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G, Pietrelli L, Gurwith M, Bowden R.
    Bone Marrow Transplant; 1999 Apr 15; 23(7):697-703. PubMed ID: 10218847
    [Abstract] [Full Text] [Related]

  • 20. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J.
    Clin Infect Dis; 2005 Nov 01; 41(9):1242-50. PubMed ID: 16206097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.